Pacira BioSciences, Inc. Cash Flow-to-Debt Ratio
Pacira BioSciences, Inc. cash flow-to-debt ratio. Pacira BioSciences, Inc. (PCRX) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2026, meaning its operating cash flow of $57.46 Million could theoretically repay 0% of its total liabilities ($572.01 Million) in one year. Check how high is Pacira BioSciences, Inc.'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pacira BioSciences, Inc. (2008–2025)
Cash flow-to-debt ratio of Pacira BioSciences, Inc. from 2008 to 2025. Historical debt coverage capacity for Pacira BioSciences, Inc. across 18 annual periods. Check PCRX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Pacira BioSciences, Inc. Cash Flow-to-Debt Ratio by Year (2008–2025)
Pacira BioSciences, Inc. cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Pacira BioSciences, Inc.. For the full cash flow conversion analysis, see Pacira BioSciences, Inc. (PCRX) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | $151.99 Million | $571.81 Million | ▲ +8.8% |
| 2024 | 0.24x | $189.39 Million | $775.17 Million | ▲ +11.3% |
| 2023 | 0.22x | $154.65 Million | $704.26 Million | ▲ +37.0% |
| 2022 | 0.16x | $145.27 Million | $906.19 Million | ▲ +71.5% |
| 2021 | 0.09x | $125.72 Million | $1.34 Billion | ▼ -20.5% |
| 2020 | 0.12x | $77.03 Million | $654.83 Million | ▼ -20.6% |
| 2019 | 0.15x | $70.52 Million | $476.12 Million | ▲ +11.6% |
| 2018 | 0.13x | $48.87 Million | $368.13 Million | ▲ +160.4% |
| 2017 | 0.05x | $17.79 Million | $348.89 Million | ▼ -73.7% |
| 2016 | 0.19x | $33.45 Million | $172.49 Million | ▲ +14.5% |
| 2015 | 0.17x | $29.00 Million | $171.23 Million | ▲ +3.0% |
| 2014 | 0.16x | $25.47 Million | $154.93 Million | ▲ +148.9% |
| 2013 | -0.34x | $-43.22 Million | $128.57 Million | ▲ +77.9% |
| 2012 | -1.52x | $-70.13 Million | $46.20 Million | ▼ -219.4% |
| 2011 | -0.48x | $-31.00 Million | $65.22 Million | ▼ -119.6% |
| 2010 | -0.22x | $-24.88 Million | $114.94 Million | ▲ +30.5% |
| 2009 | -0.31x | $-20.84 Million | $66.90 Million | ▲ +54.1% |
| 2008 | -0.68x | $-29.19 Million | $43.05 Million | — |